Literature DB >> 21422423

Can quantifying hormone receptor levels guide the choice of adjuvant endocrine therapy for breast cancer?

John R Mackey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21422423     DOI: 10.1200/JCO.2010.34.3202

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Adjuvant Hormonal Therapy in Postmenopausal Women with Breast Cancer: Physician's Choices.

Authors:  Asim Jamal Shaikh; Shiyam Kumar; Sajjad Raza; Maria Mehboob; Osama Ishtiaq
Journal:  Int J Breast Cancer       Date:  2012-12-09

2.  Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype.

Authors:  Marco M Hefti; Rong Hu; Nicholas W Knoblauch; Laura C Collins; Benjamin Haibe-Kains; Rulla M Tamimi; Andrew H Beck
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.